INNT
TOTAL INVALIDATION PROCESSED BY THE IB
11/09/2024
Back to search
Official data from USPTO
HYALOFTIL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HYALOFTIL
ST13
US500000079190523Class
1, 3, 5
Filing
79190523
Registration
5243378
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
11/09/2024
Trademark type
Word
Nice classes
1, 3, 5
Filing date
02/19/2016
Registration date
07/18/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/02/2024
Last transaction
02/02/2024
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
IT
Examiner
SABLE, ERIC
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
FIDIA FARMACEUTICI S.p.A.
Representatives
Andrew N. Fredbeck Fross Zelnick Lehrman & Zissu, P.C.
Technical classification
Nice Classes
Class 1Class 3Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Industrial chemicalschemical preparations for scientific purposes other than for medical or veterinary use; chemical preparations for use in photography; raw material and intermediates based on hyaluronic acid or its derivatives and esters for use in the manufacture of other goods; chemical productshyaluronic acid esters or derivatives for the manufacturing of pharmaceutical and cosmetic preparations
Class 3
Medicated soaps; deodorant soaps; antiperspirant soaps; perfumerycosmeticshair lotions; dentifrices; cosmetic creams; cosmetic preparations for skin care; pomades for cosmetic purposes; dental bleaching gels; douching preparations for personal sanitary or deodorant purposes; massage gels other than for medical purposes; lip glosses; lipsticks
Class 5
Pharmaceutical preparations for the treatment of dermatological diseases and wrinkles; injectable dermal fillers; veterinary preparations for the treatment of joint diseases in horses; ophthalmic preparations for use in eye surgery; ophthalmic collyrium and tear substitutes; eye drops; medical adjuvants based on hyaluronic acid for use in ophthalmic surgery and ophthalmology; pharmaceutical preparations for the care of the mouth and teeth; pharmaceutical preparations for use in otorhinolaryngology; pharmaceutical preparations for the treatment of joint diseases; pharmaceutical preparations for the treatment of pathologies of the muscular and skeletal system; disinfectants
Publications
History of USPTO decisions and trademark events.
37 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
10/17/2024
INPC
INVALIDATION PROCESSED
10/17/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
10/03/2024
C71T
CANCELLED SECTION 71
02/02/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/18/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/06/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
01/30/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/10/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/23/2017
FIMP
FINAL DISPOSITION PROCESSED
10/23/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/18/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
07/18/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/02/2017
PUBO
PUBLISHED FOR OPPOSITION
05/02/2017
GPNX
NOTIFICATION PROCESSED BY IB
04/29/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/12/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/12/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/12/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/22/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/21/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/20/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/20/2017
RFNT
REFUSAL PROCESSED BY IB
11/11/2016
CNRT
NON-FINAL ACTION MAILED
09/22/2016
CNRT
NON-FINAL ACTION WRITTEN
09/22/2016
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
09/22/2016
RFNT
REFUSAL PROCESSED BY IB
09/16/2016
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
09/16/2016
MAFR
APPLICATION FILING RECEIPT MAILED
08/30/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/29/2016
RFRR
REFUSAL PROCESSED BY MPU
08/29/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/27/2016
CNRT
NON-FINAL ACTION WRITTEN
08/26/2016
DOCK
ASSIGNED TO EXAMINER
08/26/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/26/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/25/2016
Continuous trademark protection
Get notified about every new filing that threatens HYALOFTIL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.